Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2015-001599-23Phase 4Active
Phase 4 trial of simvastatin in schizophrenia (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Change in [11C]PK11195 BPnd after simvastatin treatment in schizophrenic patients. Started Apr 2015; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2015-001599-23.